Articles tagged "Recurrence"

2020 American Transplant Congress
Hepatocellular Carcinoma Recurrence after Severe Acute Cellular Rejection
M. Najjar¹, O. Perez¹, K. Bruestle¹, A. Qian¹, P. Jiang¹, A. Srivastava¹, Y. Saenger¹, E. Verna¹, E. Zheng¹, A. Mathur¹, A. Griesemer¹, K. Halazun², B. Samstein², T. Kato¹, J. Emond¹
¹Columbia University Irving Medical Center, New York, NY, ²Weill Cornell Medicine, New York, NY
*Purpose: The interplay between acute cellular rejection (ACR), immunosuppression and hepatocellular carcinoma (HCC) recurrence in patients who underwent liver transplantation (LT) for HCC is still…
2020 American Transplant Congress
A Long-Term Follow-Up Study of High-Dose Intravenous Cyclosporine Combined Plasma Exchange in the Treatment of FSGS Recurrence after Renal Transplantation – A Single Center Clinical Experience
Y. Cui, M. F. Wang, C. C. Wei, J. Y. Wu
Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
*Purpose: There was still lack of effective treatment for focal segmental glomerulosclerosis(FSGS)recurrence after renal transplantation. The purpose of this study was to explore the risk…
2020 American Transplant Congress
Beyond Milan- Not Paying the Price
A. Mathur, C. Brennan, D. Tsapepas, M. Najjar, O. Perez, A. Griesemer, T. Kato, J. Emond
Columbia University, New york, NY
*Purpose: Early stage hepatocellular carcinoma (HCC) patients meeting the Milan Criteria have access to Orthotopic Liver Transplantation (OLT) as a curative treatment. However, a substantial…
2020 American Transplant Congress
Imaging Features and Diagnostic Accuracy of MRI in Combined Hepatocholangiocarcinoma
M. Najjar¹, J. Makkar¹, S. Sun¹, J. Zou¹, O. Perez¹, P. Jiang¹, Y. Saenger¹, E. Zheng¹, E. Verna¹, A. Mathur¹, A. Griesemer¹, K. Halazun², B. Samstein², T. Kato¹, J. Emond¹
¹Columbia University Medical Center/New-York Presbyterian, New York, NY, ²Weill Cornell Medicine, New York, NY
*Purpose: Combined hepatocholangiocarcinomas (HCC-CCA) are rare tumors with both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) differentiations. They are usually associated with a worse prognosis after…
2020 American Transplant Congress
Methenamine for Prevention of Recurrent Urinary Tract Infections in Adult Solid Organ Transplant Recipients
H. Sweiss¹, S. Bhayana², R. Hall¹, J. Nelson¹, E. Kincaide¹
¹University Health System, The University of Texas at Austin, College of Pharmacy, Pharmacotherapy Division, Austin, TX, The University of Texas Health Science Center at San Antonio, San Antonio, TX, ²University Health System, The University of Texas Health Science Center at San Antonio, San Antonio, TX
*Purpose: Evaluate efficacy of methenamine for prevention of recurrent urinary tract infections (rUTI) in transplant recipients.*Methods: This retrospective review included patients greater than or equal…
2020 American Transplant Congress
Prognostic Impact of Peritumoral Neutrophil Infiltration on Hepatocellular Carcinoma Recurrence Following Liver Transplantation
M. Najjar¹, K. Halazun², M. Mondal¹, A. Srivastava¹, M. Moore¹, E. Rizk¹, R. Gartrell¹, H. Remotti¹, L. Fazlollahi¹, E. Verna¹, A. Griesemer¹, A. Mathur¹, B. Samstein², J. Emond¹, Y. Saenger¹
¹Columbia University Irving Medical Center, New York, NY, ²Weill Cornell Medicine, New York, NY
*Purpose: Peritumoral neutrophil (PMN) infiltration has been associated with poor clinical outcomes in various tumors; however, its role in hepatocellular carcinoma (HCC) remains understudied. Moreover,…
2020 American Transplant Congress
Recurrent Focal Segmental Glomerulosclerosis and the Possibility of Re-Transplantation
E. L. Wood¹, J. Burrows¹, E. Lum, MD², J. Veale, MD¹
¹Urology, UCLA, Los Angeles, CA, ²Nephrology, UCLA, Los Angeles, CA
*Purpose: Up to 30% of patients with focal segmental glomerulosclerosis (FSGS) experience recurrent disease after renal transplant, with high rates of progression to allograft failure…
2020 American Transplant Congress
Factors Associated with Hepatocellular Carcinoma Understaging for Liver Transplantation, and Variation in Understaging by Transplant Center
N. Mahmud¹, M. Hoteit¹, D. Goldberg²
¹Hospital of the University of Pennsylvania, Philadelphia, PA, ²University of Miami, Miami, FL
*Purpose: Hepatocellular carcinoma (HCC) may be cured by liver transplantation (LT) in selected patients, though recurrence rates remain high. Patients who are reported as within…
2020 American Transplant Congress
Risk Factors of Focal Segmental Glomerulosclerosis Recurrence in Pediatric Kidney Transplant Recipients : Single Center Experience
C. T. Chung, H. Ko, H. Mo, H. Kim, A. Han, S. Min, J. Ha
Seoul National University, College of Medicine, Seoul, Korea, Republic of
*Purpose: Focal segmental glomerulosclerosis (FSGS) is one of the most common causes of end stage renal diseases (ESRD) in children. Many pediatric patients diagnosed with…
2020 American Transplant Congress
Prognostic Index of Circulating Tumor Cells for Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation
M. Chen¹, Z. Chen¹, X. Lin², W. Ju¹, X. He¹
¹Transplant Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Division of General Surgery, The Eastern Hospital of the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: Liver transplantation (LT) is an effective option for hepatocellular carcinoma (HCC) and end-stage liver cirrhosis. However, organ shortage and tumor recurrence are the main…